Skip to Main Content

SAN FRANCISCO — At the J.P. Morgan Healthcare Conference, as in life, scheduling is everything.

Several hundred biopharma companies scored an invitation to give a corporate presentation during this week’s industry confab — but they won’t all have an equal chance to win over investors. Some will be presenting in more glamorous rooms, with more room to fit more investors, on a day more likely to draw an energized crowd.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED